F M Marincola Selected Research

Antigens

1/2016	Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015.
12/2001	Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials: a preliminary look.
12/2001	Antigen presentation of a modified tumor-derived peptide by tumor infiltrating lymphocytes.
11/2001	Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases.
7/2001	Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.
5/2001	T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.
3/2001	Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.
8/2000	Tyrosinase immunoreactivity in fine-needle aspiration samples of metastatic malignant melanoma.
7/2000	Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.
6/2000	Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F M Marincola Research Topics

Disease

27	Melanoma (Melanoma, Malignant) 01/2016 - 01/2000
27	Neoplasms (Cancer) 01/2016 - 01/2000
5	Neoplasm Metastasis (Metastasis) 11/2001 - 04/2000
2	Lung Neoplasms (Lung Cancer) 07/2011 - 12/2010
2	Infections 09/2003 - 03/2000
2	Testicular Neoplasms (Testicular Cancer) 03/2001 - 06/2000
1	Nasopharyngeal Carcinoma 05/2013
1	Adenocarcinoma 07/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2011
1	Carcinogenesis 12/2010
1	Genetic Translocation (Chromosomal Translocation) 09/2001
1	Sarcoma (Soft Tissue Sarcoma) 09/2001
1	Thoracic Neoplasms 03/2001
1	Oral Candidiasis (Thrush) 03/2001
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2001
1	Pain (Aches) 03/2001
1	Thrombocytopenia (Thrombopenia) 01/2000

Drug/Important Bio-Agent (IBA)

12	AntigensIBA 01/2016 - 03/2000
10	EpitopesIBA 09/2003 - 01/2000
9	Peptides (Polypeptides)IBA 12/2001 - 03/2000
7	Proteins (Proteins, Gene)FDA Link 12/2014 - 01/2000
7	VaccinesIBA 09/2001 - 01/2000
6	HLA-A*02:01 antigenIBA 09/2003 - 01/2000
5	CytokinesIBA 07/2013 - 08/2000
4	HLA Antigens (Human Leukocyte Antigens)IBA 07/2001 - 01/2000
4	Monophenol Monooxygenase (Tyrosinase)IBA 08/2000 - 01/2000
3	Interleukin-2 (IL2)IBA 10/2013 - 03/2001
3	DNA (Deoxyribonucleic Acid)IBA 07/2011 - 03/2001
3	Messenger RNA (mRNA)IBA 12/2010 - 01/2000
2	MicroRNAs (MicroRNA)IBA 07/2011 - 12/2010
2	RNA (Ribonucleic Acid)IBA 07/2011 - 12/2010
2	Interleukin-10 (Interleukin 10)IBA 12/2004 - 07/2001
2	Cancer VaccinesIBA 02/2002 - 03/2001
2	Melanoma-Specific AntigensIBA 11/2001 - 01/2000
2	ElementsIBA 11/2001 - 04/2000
2	Interferon-gamma (Interferon, gamma)IBA 09/2001 - 01/2000
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2001 - 01/2000
2	Complementary DNA (cDNA)IBA 01/2001 - 04/2000
2	Differentiation AntigensIBA 06/2000 - 04/2000
1	Immune Checkpoint InhibitorsIBA 01/2016
1	Connective Tissue Growth FactorIBA 05/2013
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 11/2001
1	A-Form DNA (A-DNA)IBA 11/2001
1	Interleukin-12 (IL 12)IBA 09/2001
1	InterleukinsIBA 09/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2001
1	Transforming Growth Factor beta2IBA 07/2001
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2001
1	romidepsin (FK228)FDA Link 03/2001
1	Decitabine FDA Link 03/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2001
1	Antifungal AgentsIBA 03/2001
1	ChromatinIBA 03/2001
1	DeoxycytidineIBA 03/2001
1	Nystatin (Mycostatin)FDA LinkGeneric 03/2001
1	DepsipeptidesIBA 03/2001
1	Histone Deacetylase InhibitorsIBA 03/2001
1	Melanins (Melanin)IBA 08/2000
1	EnzymesIBA 08/2000
1	gp100 Melanoma AntigenIBA 06/2000
1	interferon tauIBA 06/2000
1	Complement System Proteins (Complement)IBA 04/2000
1	HLA-B Antigens (HLA-B)IBA 03/2000
1	HLA-A24 AntigenIBA 03/2000
1	HLA-A Antigens (HLA-A)IBA 03/2000
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2000
1	ChemokinesIBA 01/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2000

Therapy/Procedure

10	Immunotherapy 01/2016 - 03/2000
7	Therapeutics 12/2014 - 01/2000
1	Aftercare (After-Treatment) 07/2013
1	Lasers (Laser) 11/2001